News
Stay with WESH 2 online and on-air for the most accurate Central Florida weather forecast.>> More: 2025 Hurricane Survival ...
Jacket's Jim James discusses how practicing self-love helped him on his journey to sobriety on the Going There with Dr. Mike ...
Today on Tracking the Tropics, we’ll have the latest on Invest-93L, which is moving across the Florida peninsula and has the chance to develop as it enters the Gulf. It’s expected to ...
The Supreme Court’s ruling in "City of Grants Pass v. Johnson" not only criminalizes homelessness but also weaponizes a ...
Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.
Johnson & Johnson ( JNJ 0.01%) has been a leading healthcare company in the world for decades, and it's one of the most ...
Several Democrats said that they currently have a grim outlook on the future of the Democratic Party, The Hill reported ...
The development saga for the depression molecule has been rocky for years, unable to ease symptoms in multiple late-stage ...
Market reaction to recent readouts from Compass Pathways and Beckley Psytech/atai in treatment-resistant depression speaks to ...
The three philanthropists devoted themselves and their resources to important causes during lifetimes of service to Palm ...
So, I can't, in good conscience, suggest anyone buy Johnson & Johnson because I wouldn't buy the stock myself right now. Should you invest $1,000 in Johnson & Johnson right now?
Alto Neuroscience’s phase 2 depression trial has missed its primary efficacy endpoint, as patients on the drug candidate fared no better on a measure of alertness and mood than their peers on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results